Is HOWL research on Rallies investment advice?

No. Rallies provides research, data, and educational context for HOWL. It does not provide personalized investment advice.

HOWL (Werewolf Therapeutics, Inc. Common Stock) Stock Analysis - Financials

Werewolf Therapeutics, Inc. Common Stock (HOWL) is a publicly traded Healthcare sector company. As of July 31, 2026, HOWL trades at $0.47 with a market cap of $22.35M and a P/E ratio of -0.38. HOWL moved -7.07% today. Year to date, HOWL is -22.39%; over the trailing twelve months it is -58.30%. Its 52-week range spans $0.27 to $2.38. Rallies surfaces HOWL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are HOWL's key financials?

HOWL financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. HOWL recently traded at $0.47. Market cap is $22.35M. P/E ratio is -0.38. Revenue is $0.

HOWL Key Metrics

Key financial metrics for HOWL
Metric	Value
Price	$0.47
Market Cap	$22.35M
P/E Ratio	-0.38
EPS	$-1.32
Dividend Yield	0.00%
52-Week High	$2.38
52-Week Low	$0.27
Volume	675.23K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-60.82M
Gross Margin	0.00%

HOWL Analyst Consensus

HOWL analyst coverage data. Average price target: $0.00.

Common questions about HOWL

What are HOWL's key financials?: HOWL financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. HOWL recently traded at $0.47. Market cap is $22.35M. P/E ratio is -0.38. Revenue is $0.
Is HOWL research on Rallies investment advice?: No. Rallies provides research, data, and educational context for HOWL. It does not provide personalized investment advice.